Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Clofazimine induced pigmentation in leprosy patches.

Chavhan S, Jawade S. The Pan African medical journal. 2022;
Download PDF
Publication

The Armadillo as a Model for Leprosy Nerve Function Impairment: Preventative and Therapeutic Interventions.

Pena M, Lahiri R, Ebenezer G, et al. Frontiers in medicine. 2022;
Download PDF
Publication

Case Report: A Case Series of Immunobiological Therapy (Anti-TNF-α) for Patients With Erythema Nodosum Leprosum.

Mendes A, Gomes C, Kurizky P, et al. Frontiers in medicine. 2022;
Download PDF
Publication

Peripheral neuropathy in leprosy: Clinical manifestations and disability in a Colombian national referral center.

Trujillo-Ramirez L, Palacios-Ariza M, Pradilla I, et al. Dermatology reports. 2022; 14 (2) : 9308.
Download PDF
Publication

Leprosy: A Review of Epidemiology, Clinical Diagnosis, and Management.

Chen K, Lin C, Bin Su S, et al. Journal of tropical medicine. 2022;
Download PDF
Publication

Multibacillary leprosy with an incubation period exceeding 50 years.

Taggart M, Kelly A, Stell R, et al. BMJ case reports. 2022;
Download PDF
Publication

Unmasking Hansen's disease through an ophthalmologist's eye.

Ahluwalia N, Choudhary P, Shakya R, et al. Indian journal of ophthalmology. 2022; 70 (7) : 2671-2673.
Download PDF
Publication

Commentary: Ocular lesions in leprosy - Should we forget?

Biswas J, Pradhan A. Indian journal of ophthalmology. 2022; 70 (7) : 2673-2674.
Download PDF
Publication

A rare cause of acquired esotropia: Leprosy.

Canleblebici M, Yildirim H, Balbaba M, et al. Indian journal of ophthalmology. 2022; 70 (7) : 2752-2754.
Download PDF
Publication

Factors Influencing Leprosy-Affected People for Migration, Distant Registration and their Effect on Leprosy Services in Bangladesh

Hossain QZ, Hadi MA, Azad-uz-zaman Q, et al. Indian Journal of Leprosy. 2022;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 236
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD